
Akihito Kawazoe, MD, discussed the safety and efficacy results of the phase I/II SCOOP trial of napabucasin plus pembrolizumab for treatment of patients with metastatic colorectal cancer.

Your AI-Trained Oncology Knowledge Connection!


Published: April 2nd 2018 | Updated: